Huang Z - Search Results

1

XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo.

Xu J, Liu X, Huang Z, Lu T, Zhang Y, Cai D, Li X. Xu J, et al. Among authors: huang z. Biochem Genet. 2024 Jul 24. doi: 10.1007/s10528-024-10885-4. Online ahead of print. Biochem Genet. 2024. PMID: 39048769

2

miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.

Qiu T, Zhou L, Wang T, Xu J, Wang J, Chen W, Zhou X, Huang Z, Zhu W, Shu Y, Liu P. Qiu T, et al. Among authors: huang z. Int J Mol Med. 2013 Sep;32(3):593-8. doi: 10.3892/ijmm.2013.1439. Epub 2013 Jul 12. Int J Mol Med. 2013. PMID: 23856992

3

Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma.

Lu M, Li J, Huang Z, Du Y, Jin S, Wang J. Lu M, et al. Among authors: huang z. Med Sci Monit. 2016 Jan 13;22:134-9. doi: 10.12659/msm.894995. Med Sci Monit. 2016. PMID: 26757744 Free PMC article.

4

miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.

Zhu M, Zhou X, Du Y, Huang Z, Zhu J, Xu J, Cheng G, Shu Y, Liu P, Zhu W, Wang T. Zhu M, et al. Among authors: huang z. Mol Med Rep. 2016 Aug;14(2):1742-50. doi: 10.3892/mmr.2016.5413. Epub 2016 Jun 21. Mol Med Rep. 2016. PMID: 27357419

5

IL7R Is Correlated With Immune Cell Infiltration in the Tumor Microenvironment of Lung Adenocarcinoma.

Wang X, Chang S, Wang T, Wu R, Huang Z, Sun J, Liu J, Yu Y, Mao Y. Wang X, et al. Among authors: huang z. Front Pharmacol. 2022 Feb 21;13:857289. doi: 10.3389/fphar.2022.857289. eCollection 2022. Front Pharmacol. 2022. PMID: 35264973 Free PMC article.

6

Clinical implication and immunological landscape analyses of ANLN in pan-cancer: A new target for cancer research.

Zhang L, Wei Y, He Y, Wang X, Huang Z, Sun L, Chen J, Zhu Q, Zhou X. Zhang L, et al. Among authors: huang z. Cancer Med. 2023 Feb;12(4):4907-4920. doi: 10.1002/cam4.5177. Epub 2022 Aug 28. Cancer Med. 2023. PMID: 36030492 Free PMC article.

7

MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.

Zou X, Xia T, Li M, Wang T, Liu P, Zhou X, Huang Z, Zhu W. Zou X, et al. Among authors: huang z. Cancer Biomark. 2021;30(1):41-53. doi: 10.3233/CBM-201547. Cancer Biomark. 2021. PMID: 32894240

8

Differentially expressed microRNA in prognosis of gastric cancer with Lauren classification.

Chen W, Guo Q, Zhang H, Du Y, Zhou Y, Huang Z, Zhang M, Qin S. Chen W, et al. Among authors: huang z. Cancer Biomark. 2024;41(1):41-54. doi: 10.3233/CBM-230303. Cancer Biomark. 2024. PMID: 39177588 Free PMC article.

9

miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1.

Zhou L, Qiu T, Xu J, Wang T, Wang J, Zhou X, Huang Z, Zhu W, Shu Y, Liu P. Zhou L, et al. Among authors: huang z. Pathol Oncol Res. 2013 Oct;19(4):677-83. doi: 10.1007/s12253-013-9630-4. Epub 2013 May 3. Pathol Oncol Res. 2013. PMID: 23640248 Free article.

10

MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.

Wang T, Ge G, Ding Y, Zhou X, Huang Z, Zhu W, Shu Y, Liu P. Wang T, et al. Among authors: huang z. Chin Med J (Engl). 2014;127(12):2357-62. Chin Med J (Engl). 2014. PMID: 24931256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,988 results

Search Page

Filters